Issues in pharmaceutical lotteries: The case of interferon beta-1b

Brown Js, Shulman, The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked? Food and Drug Law Journal. ,vol. 50, pp. 503- ,(1995)

Karen Davis, Inequality and Access to Health Care The Milbank Quarterly. ,vol. 69, pp. 253- 273 ,(1991) , 10.2307/3350204

L. Scapol, P. Rappuoli, G.C. Viscomi, Purification of recombinant human interferon-β by immobilized antisense peptides Journal of Chromatography A. ,vol. 600, pp. 235- 242 ,(1992) , 10.1016/0021-9673(92)85553-6

Analee E. Beisecker, Patient Power in Doctor-Patient Communication: What Do We Know? Health Communication. ,vol. 2, pp. 105- 122 ,(1990) , 10.1207/S15327027HC0202_4

Sheila R. Shulman, Patricia A. Dicerbo, Marianne E. Ulcickas, Louis Lasagna, A Survey of Therapeutic Substitution Programs in Ten Boston Area Hospitals Drug Information Journal. ,vol. 26, pp. 41- 52 ,(1992) , 10.1177/009286159202600105

Marilyn E. Gosse, Michael Manocchia, THE FIRST BIOPHARMACEUTICALS APPROVED IN THE UNITED STATES: 1980-1994 Drug Information Journal. ,vol. 30, pp. 991- 1001 ,(1996) , 10.1177/009286159603000416

D.E. Goodkin, Interferon beta-1b. The Lancet. ,vol. 344, pp. 1057- 1060 ,(1994) , 10.1016/S0140-6736(94)91713-2

Lawrence R. Jacobs, Robert Y. Shapiro, Eli C. Schulman, Poll Trends: Medical Care in the United States-an Update Public Opinion Quarterly. ,vol. 57, pp. 394- 427 ,(1993) , 10.1086/269384

Taylor Mr, USDA's agenda for change to improve food safety. Food and Drug Law Journal. ,vol. 50, pp. 385- ,(1995)

Kenneth I. Kaitin, Michael Manocchia, Mark Seibring, Louis Lasagna, The new drug approvals of 1990, 1991, and 1992: trends in drug development. The Journal of Clinical Pharmacology. ,vol. 34, pp. 120- 127 ,(1994) , 10.1002/J.1552-4604.1994.TB03975.X